middle.news

Bioxyne Eyes $75M Revenue with German Cannabis Contract Boost

4:21am on Saturday 30th of August, 2025 AEST Pharmaceuticals
Read Story

Bioxyne Eyes $75M Revenue with German Cannabis Contract Boost

4:21am on Saturday 30th of August, 2025 AEST
Key Points
  • FY2026 revenue guidance set at $65M–$75M
  • EBITDA forecast between $11.5M and $13.5M
  • New manufacturing and supply contracts in Australia
  • Maiden $5.8M contract secured in Germany with shipments starting September
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about BXN
OPEN ARTICLE